194 related articles for article (PubMed ID: 16361415)
1. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.
Clark RH; Kenyon JC; Bartlett NW; Tscharke DC; Smith GL
J Gen Virol; 2006 Jan; 87(Pt 1):29-38. PubMed ID: 16361415
[TBL] [Abstract][Full Text] [Related]
2. Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
Sumner RP; Ren H; Ferguson BJ; Smith GL
Vaccine; 2016 Sep; 34(40):4827-34. PubMed ID: 27544585
[TBL] [Abstract][Full Text] [Related]
3. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
[TBL] [Abstract][Full Text] [Related]
5. Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice.
Russell TA; Tscharke DC
Immunol Cell Biol; 2014; 92(5):466-9. PubMed ID: 24566805
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
Ryerson MR; Shisler JL
Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
[TBL] [Abstract][Full Text] [Related]
7. Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy.
Sumner RP; Ren H; Smith GL
J Gen Virol; 2013 May; 94(Pt 5):1121-1126. PubMed ID: 23288427
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
Staib C; Kisling S; Erfle V; Sutter G
J Gen Virol; 2005 Jul; 86(Pt 7):1997-2006. PubMed ID: 15958679
[TBL] [Abstract][Full Text] [Related]
9. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence.
Ng A; Tscharke DC; Reading PC; Smith GL
J Gen Virol; 2001 Sep; 82(Pt 9):2095-2105. PubMed ID: 11514718
[TBL] [Abstract][Full Text] [Related]
10. Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.
Falivene J; Del Médico Zajac MP; Pascutti MF; Rodríguez AM; Maeto C; Perdiguero B; Gómez CE; Esteban M; Calamante G; Gherardi MM
PLoS One; 2012; 7(2):e32220. PubMed ID: 22384183
[TBL] [Abstract][Full Text] [Related]
11. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
[TBL] [Abstract][Full Text] [Related]
12. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
Ramírez JC; Gherardi MM; Esteban M
J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755
[TBL] [Abstract][Full Text] [Related]
13. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
[TBL] [Abstract][Full Text] [Related]
14. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.
Mathew A; O'Bryan J; Marshall W; Kotwal GJ; Terajima M; Green S; Rothman AL; Ennis FA
PLoS One; 2008 Oct; 3(10):e3323. PubMed ID: 18830408
[TBL] [Abstract][Full Text] [Related]
15. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
16. Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.
García-Arriaza J; Arnáez P; Gómez CE; Sorzano CÓ; Esteban M
PLoS One; 2013; 8(6):e66894. PubMed ID: 23826170
[TBL] [Abstract][Full Text] [Related]
17. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.
Ren H; Ferguson BJ; Maluquer de Motes C; Sumner RP; Harman LE; Smith GL
Immunology; 2015 May; 145(1):34-49. PubMed ID: 25382035
[TBL] [Abstract][Full Text] [Related]
19. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of A41, a vaccinia virus chemokine binding protein.
Bahar MW; Kenyon JC; Putz MM; Abrescia NG; Pease JE; Wise EL; Stuart DI; Smith GL; Grimes JM
PLoS Pathog; 2008 Jan; 4(1):e5. PubMed ID: 18208323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
